Sulforaphane Reverses Chemo-Resistance to Temozolomide in Glioblastoma Cells by NF-κB-dependent Pathway Downregulating MGMT Expression

International Journal of Oncology - Greece
doi 10.3892/ijo.2015.3271
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Spandidos Publications

Related search

Sulforaphane Sensitizes Human Breast Cancer Cells to Paclitaxel‑induced Apoptosis by Downregulating the NF‑κB Signaling Pathway

Oncology Letters
Cancer ResearchOncology
2017English

JNK Contributes to Temozolomide Resistance of Stem-Like Glioblastoma Cells via Regulation of MGMT Expression

International Journal of Oncology
Cancer ResearchOncology
2013English

A Novel Enhancer Regulates MGMT Expression and Promotes Temozolomide Resistance in Glioblastoma

Nature Communications
AstronomyGeneticsMolecular BiologyBiochemistryChemistryPhysics
2018English

Temozolomide Resistance in Glioblastoma Cell Lines: Implication of MGMT, MMR, P-Glycoprotein and CD133 Expression

PLoS ONE
Multidisciplinary
2015English

Up-Regulation of miR-370-3p Restores Glioblastoma Multiforme Sensitivity to Temozolomide by Influencing MGMT Expression

Scientific Reports
Multidisciplinary
2016English

Genome‐Wide CRISPR‐Cas9 Screening Identifies NF‐κB/E2F6 Responsible for EGFRvIII‐Associated Temozolomide Resistance in Glioblastoma

Advanced Science
Materials ScienceGeneticsMolecular BiologyBiochemistryEngineeringChemical EngineeringMedicineAstronomyPhysics
2019English

Matrine Suppresses Invasion of Castration-Resistant Prostate Cancer Cells by Downregulating MMP-2/9 via NF-κB Signaling Pathway

International Journal of Oncology
Cancer ResearchOncology
2016English

Hydroxylase-Dependent Regulation of the NF-κB Pathway

Biological Chemistry
BiochemistryClinical BiochemistryMolecular Biology
2013English

Disruption of NF-κB Signaling by Fluoxetine Attenuates MGMT Expression in Glioma Cells

OncoTargets and Therapy
OncologyPharmacology
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy